Pharmaceutical News

RSS
California issues alert and warning about flu vaccine price gouging

California issues alert and warning about flu vaccine price gouging

FDA and MHRA to cooperate efforts to address manufacturing concerns related Chiron's influenza vaccine

FDA and MHRA to cooperate efforts to address manufacturing concerns related Chiron's influenza vaccine

CDC and Aventis Pasteur plan to allocate influenza vaccine

CDC and Aventis Pasteur plan to allocate influenza vaccine

New survey reveals continued drug price disparities across the New York State

New survey reveals continued drug price disparities across the New York State

Pharmacists respond to unprecedented demand for the flu vaccine in the wake of the current shortage

Pharmacists respond to unprecedented demand for the flu vaccine in the wake of the current shortage

HHS awards contracts totaling more than $232 million to fund development of new vaccines against smallpox, plague and tularemia

HHS awards contracts totaling more than $232 million to fund development of new vaccines against smallpox, plague and tularemia

Flu vaccine shortage highlights need to accelerate the approval of affordable generic biopharmaceuticals and vaccines

Flu vaccine shortage highlights need to accelerate the approval of affordable generic biopharmaceuticals and vaccines

Aspirin might well be considered the top utility player in the medicine cabinet

Aspirin might well be considered the top utility player in the medicine cabinet

Vioxx: an unequal partnership between safety and efficacy

Vioxx: an unequal partnership between safety and efficacy

Canadian Rheumatology Association issues statement on Vioxx alternatives

Canadian Rheumatology Association issues statement on Vioxx alternatives

EMEA statement following withdrawal of Vioxx (rofecoxib)

EMEA statement following withdrawal of Vioxx (rofecoxib)

Ireland's Department of Health has resolved outstanding concerns over the availability of flu vaccines

Ireland's Department of Health has resolved outstanding concerns over the availability of flu vaccines

U.S. healthcare industry reaction to the withdrawal of Vioxx from the world-wide market

U.S. healthcare industry reaction to the withdrawal of Vioxx from the world-wide market

U.S. Department of Health and Human Services responds to loss of Chiron flu vaccine

U.S. Department of Health and Human Services responds to loss of Chiron flu vaccine

RiboNovix secures license to novel anti-infective discovery technology from Wayne State University

RiboNovix secures license to novel anti-infective discovery technology from Wayne State University

Natural alternatives to osteoarthritis drug

Natural alternatives to osteoarthritis drug

Teva Pharmaceuticals granted final approval for Ribavirin capsules

Teva Pharmaceuticals granted final approval for Ribavirin capsules

A trial of beta-interferon-1a in inclusion-body myositis has failed to find benefit from the drug in this disease

A trial of beta-interferon-1a in inclusion-body myositis has failed to find benefit from the drug in this disease

Analysis shows Teriparatide reduces fracture risk independent of bone turnover

Analysis shows Teriparatide reduces fracture risk independent of bone turnover

Immediate voluntary world-wide withdrawal of Vioxx (rofecoxib)

Immediate voluntary world-wide withdrawal of Vioxx (rofecoxib)

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.